Related Experiment Video
Updated: Sep 29, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Angioplasty And stenting For symptomatic intracranial atherosclerotic disease: How I Do It
Ermias A Mekonnen1, Wondwossen G Tekle1,2, Sohum K Desai1,2
1Department of Neuroscience, Valley Baptist Medical Center, Harlingen, TX, USA.
Insights
Intracranial atherosclerotic disease (ICAD) causes recurrent strokes. Recent studies show Balloon-mounted stents (BMS) offer a safer endovascular treatment option for symptomatic ICAD, with lower complication rates than previous trials.
Area of Science:
- Neurology
- Vascular Medicine
- Interventional Cardiology
Background:
- Intracranial atherosclerotic disease (ICAD) is a significant cause of ischemic stroke.
- High rates of recurrent stroke occur despite optimal medical management.
- Endovascular treatment for ICAD remains controversial due to historical complication rates.
Purpose of the Study:
- To review the recent advancements in endovascular therapy for symptomatic ICAD.
- To evaluate the safety and efficacy of newer endovascular techniques.
Main Methods:
- Review of recent multicenter prospective studies on stent placement for ICAD.
- Comparison of periprocedural complication rates with historical trials (SAMMPRIS, VISSIT).
- Focus on Balloon-mounted stents (BMS) in symptomatic high-grade intracranial stenosis.
Main Results:
- A recent prospective study demonstrated significantly lower periprocedural stroke rates (5.6%) with BMS compared to historical trials (SAMMPRIS: 14.7%, VISSIT: 21.4%).
- This suggests improved safety profiles for contemporary endovascular approaches.
- Balloon-mounted stents show promise in managing symptomatic ICAD.
Conclusions:
- Endovascular therapy for symptomatic ICAD has evolved, offering improved safety.
- Balloon-mounted stents represent a viable and potentially safer option for selected ICAD patients.
- Further research and clinical adoption of refined endovascular techniques are warranted.
Abstract:
Intracranial atherosclerotic disease (ICAD) is a common cause of acute ischemic stroke. ICAD has a high rate of recurrent ischemic stroke despite recommended adequate medical treatment. Endovascular treatment of ICAD has been controversial due to high periprocedural complication in historic randomized clinical trials (RCTs). Recently, a multicenter prospective study of stent placement in patients with high grade intracranial stenosis that evaluated safety and efficacy of Balloon-mounted stents (BMS) in symptomatic ICAD showed low rates of periprocedural stroke (5.6%) than the SAMMPRIS (14.7%) and VISSIT (21.4%) trials. This review highlights the recent evolution of endovascular therapy for symptomatic ICAD.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Aneurysm III: Interprofessional Care
Angina IV: Management
Atherosclerosis III: Management
Acute Coronary Syndrome IV: Interprofessional Care

